Bilimetrix Overview

Founded 2011
Status Private
Employees 3
Latest Deal Type Grant
Latest Deal Amount $56.2K
Latest Deal Amount
Investors 7

Bilimetrix General Information


Operator of research and development biomedical company. The company develops a point of care (POC) system for early diagnosis of hyperbilirubinemia which will be used as a screening diagnostic to estimate the plasma total bilirubin concentration, triage newborns and evaluate risk of hyperbilirubinemia during discharge from birthing centers and to assess severity of jaundice in newborns during follow up visits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare
Diagnostic Equipment
Primary Office
  • AREA Science Park
  • Building Q
  • 34149 Trieste
  • Italy
+39 040 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bilimetrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 28-Oct-2015 $56.2K 0000 Completed Startup
2. Grant 21-Aug-2013 0000 Completed Startup
1. Accelerator/Incubator 21-Dec-2012 $13K $13K Completed Startup

Bilimetrix Executive Team (2)

Name Title Board Seat Contact Info
Claudio Tiribelli Ph.D Chief Executive Officer & Partner
Richard Wennberg MD Co-Founder & Partner

Bilimetrix Investors (7)

To view Bilimetrix‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Government of Canada Government 000 0000 000000 0
Government of Norway Government 000 0000 000000 0
The Department for Business, Innovation & Skills - UK Limited Partner 000 0000 000000 0

Ready to get started?

Request a free trial